JP2008526880A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526880A5
JP2008526880A5 JP2007550515A JP2007550515A JP2008526880A5 JP 2008526880 A5 JP2008526880 A5 JP 2008526880A5 JP 2007550515 A JP2007550515 A JP 2007550515A JP 2007550515 A JP2007550515 A JP 2007550515A JP 2008526880 A5 JP2008526880 A5 JP 2008526880A5
Authority
JP
Japan
Prior art keywords
glutamyl
optionally substituted
compound according
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007550515A
Other languages
English (en)
Japanese (ja)
Other versions
JP4903717B2 (ja
JP2008526880A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/000532 external-priority patent/WO2006074409A1/en
Publication of JP2008526880A publication Critical patent/JP2008526880A/ja
Publication of JP2008526880A5 publication Critical patent/JP2008526880A5/ja
Application granted granted Critical
Publication of JP4903717B2 publication Critical patent/JP4903717B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007550515A 2005-01-06 2006-01-05 トリペプチドおよびテトラペプチドスルホン Expired - Fee Related JP4903717B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64193205P 2005-01-06 2005-01-06
US60/641,932 2005-01-06
PCT/US2006/000532 WO2006074409A1 (en) 2005-01-06 2006-01-05 Tripeptide and tetrapeptide sulfones

Publications (3)

Publication Number Publication Date
JP2008526880A JP2008526880A (ja) 2008-07-24
JP2008526880A5 true JP2008526880A5 (https=) 2009-02-19
JP4903717B2 JP4903717B2 (ja) 2012-03-28

Family

ID=36123437

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007550441A Expired - Fee Related JP4903716B2 (ja) 2005-01-06 2006-01-04 トリペプチドおよびテトラペプチドチオエーテル
JP2007550515A Expired - Fee Related JP4903717B2 (ja) 2005-01-06 2006-01-05 トリペプチドおよびテトラペプチドスルホン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007550441A Expired - Fee Related JP4903716B2 (ja) 2005-01-06 2006-01-04 トリペプチドおよびテトラペプチドチオエーテル

Country Status (24)

Country Link
US (2) US7129215B2 (https=)
EP (2) EP1833978B1 (https=)
JP (2) JP4903716B2 (https=)
KR (2) KR101244609B1 (https=)
CN (2) CN101090977B (https=)
AR (2) AR051889A1 (https=)
AT (2) ATE410520T1 (https=)
AU (2) AU2006204022B2 (https=)
BR (2) BRPI0606520A2 (https=)
CA (2) CA2587284C (https=)
DE (2) DE602006003064D1 (https=)
DK (2) DK1833978T3 (https=)
EA (2) EA200701398A1 (https=)
ES (2) ES2314890T3 (https=)
HR (2) HRP20090128T3 (https=)
IL (2) IL182836A (https=)
MX (2) MX2007008255A (https=)
NZ (2) NZ555362A (https=)
PL (2) PL1833978T3 (https=)
PT (2) PT1833978E (https=)
SI (2) SI1833978T1 (https=)
TW (2) TWI317739B (https=)
WO (2) WO2006074249A1 (https=)
ZA (2) ZA200704487B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198247B2 (en) 2004-12-21 2012-06-12 Telik, Inc. Process for and intermediates in the preparation of canfosfamide and its salts
BRPI0606520A2 (pt) * 2005-01-06 2009-06-30 Telik Inc tripeptìdeo e tetrapeptìdeo tioéteres
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
WO2008056207A1 (en) * 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
WO2008149181A1 (en) 2007-06-04 2008-12-11 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
WO2010065936A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
DE102008060888A1 (de) 2008-12-09 2010-06-10 Evonik Stockhausen Gmbh Verfahren zur Herstellung von Acrolein umfassend die Aufarbeitung einer Rohglycerin-Phase
EP2427475B1 (en) 2009-05-08 2020-11-04 Techfields Biochem Co., Ltd. High penetration prodrug compositions of peptides and peptide-related compounds
CA2797458A1 (en) * 2010-06-07 2011-12-15 Telik, Inc. Tablet formulation of ezatiostat
JP2013528214A (ja) 2010-06-07 2013-07-08 テリック,インコーポレイテッド 結晶性エザチオスタット塩酸塩非溶媒和物d型の調製
US20130035389A1 (en) * 2011-08-05 2013-02-07 Telik, Inc. Methods for treating myelodysplastic syndrome with ezatiostat
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
CN106146616A (zh) * 2015-04-03 2016-11-23 浙江海正药业股份有限公司 环肽类化合物及其制备和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599903A (en) 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5556942A (en) 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
US5955432A (en) 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
US5767086A (en) 1992-04-03 1998-06-16 Terrapin Technologies, Inc. Bone marrow stimulation by certain glutathione analogs
CA2105492C (en) * 1993-09-03 2000-02-01 Lawrence M. Kauvar Glutathione analogs and paralog panels comprising glutathione mimics
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
JPH11507056A (ja) * 1995-06-07 1999-06-22 テラピン テクノロジーズ、インク. グルタチオンアナログの代謝的効果
AU4124697A (en) * 1996-09-02 1998-03-26 Manchester Metropolitan University, The S-blocked glutathiones
TW576838B (en) * 1998-04-16 2004-02-21 Teijin Ltd Glutathione derivatives and application form thereof
ATE286741T1 (de) 1999-01-27 2005-01-15 Telik Inc Glutathioneanaloge enthaltende therapeutische zusammensetzungen
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
BRPI0606520A2 (pt) * 2005-01-06 2009-06-30 Telik Inc tripeptìdeo e tetrapeptìdeo tioéteres

Similar Documents

Publication Publication Date Title
JP2008526880A5 (https=)
JP2009544611A5 (https=)
JP2008526859A5 (https=)
JP2007016035A5 (https=)
JP2008533191A5 (https=)
JP2009520017A5 (https=)
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
WO2005021519A3 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
JP2016512203A5 (https=)
JP2005533827A5 (https=)
JP2014531441A5 (https=)
JP2013544276A5 (https=)
JP2012510502A5 (https=)
JPWO2012144463A1 (ja) 腫瘍治療剤
JP2010520893A5 (https=)
JP2011517697A5 (https=)
JP2005505583A5 (https=)
JP2012508251A5 (https=)
JP2004524279A5 (https=)
JP2009501745A5 (https=)
JP2007522111A5 (https=)
JP2012501334A5 (https=)
RU2004138595A (ru) Соединения, применяемые при лечении сибирской язвы и ингибирующие летальный фактор
JP2015534567A5 (https=)
JP2005501091A5 (https=)